Character Group PLC (PK) (CGROF) News

the 73 coauthors actually did point out the lack of individual patient data which is the discussion here

You were so convinced this was moving up to your top shelf.

They (especially Girsky) said a lot more after the Q2 results , explaining their approach to national accounts to get the committed volumes so they can negotiate with the supplier to get realistic volume pricing. Especially for expensive items not just the Fuel cell but wiring and radiators (which

I think shareholders should be questioning if whether the chairman is acting in the best fudiciary duty to gncp shareholders

Brother, give all the investment advice you like, but spend enough time with lawyers and you likely won't.

100% agree
First was the fda required it and second was crossover was needed to get people to join the trial as no one wants to be the control.
therefore I suspect the SurVaxM will have a lot of trouble finding patients willing to die so they can be compared with the treatment arm

~ ASPI $7.81 With 8k confirmation...


[aspi_8k.htm](http://archive.fast-edgar.com/20241104/A6ZZBG2CZ22FKZQX222R2ZZ2G5MDZZ28Z962/)

CTM.......GRI......NUWE.........HRYU........,,,,,,,,,,,,,,,,,,,,,,,,,,,p/m

Well equally Blarcamesine (pooled) had 5.4% with falls vs placebo who had 11.9% with falls meaning falls were reduced 55% when Blarcamesine was involved. Or put another way placebo group had more than double the % number of falls as Blarca.
Considering you and the market have not made much of

Pulsar Helium Completes Key Site Improvements At
Topaz Project, Setting Stage For Next Phase Of
Drilling
2024-11-04
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR I

No doubt in my mind that Brian Lewis formally worked for the Agency…

We are in good hands.

We are golden…!

$MONI

MOO

Put on your sunglasses blue skies up ahead

Sorry boys but I think BOPO should switch ticker symbol to BOBO (the clown).
Still not trading after 1/2 year.
Unreal. What a mess.

So why would the FDA be so inflexible in asking for the comparison of patient
level matched controls when that RA should have known that in the case that
their post progression DCVax-L treatment mandate could nix the placebo
group, the trial results, no matter how positive, coul

As always---excellent reply---thanks

NLST In 3 days: Netlist vs. Micron in Munich.

200mm matters. Wow. KCC has checked out.

It’s as if you missed everything I’ve said about this.

You act like it would not matter if only one foundry is able to make lightwave modulators on a 200 mm wafer.

Since I don’t believe you are ignorant, I can o

Huge news . This will be great for investors to see our name. 

Good morning

Sparkling, not my opinion it is what fda told management officer of mimivax with similar results on gbm that they could use external controls if they had matched patient level data but if not must have control group so their next trial is randomized 3 to 2.
The number of authors on the jama p

Time for a pullback to lower $2s

good morning all... $ELAB .024 lotto play

Nvidia Corp (NASDAQ:NVDA) CEO Jensen Huang has requested SK Hynix Inc. (OTC:HXSCF) to expedite the supply of its next-generation high-bandwidth memory chips by six months.
https://charts.stocktwits-cdn.com/production/original_591055376.png